22 Studies and Reports Raise Doubts About COVID Vaccine Efficacy and Vaccinating Children
The evidence showing COVID vaccines are not as efficacious as advertised against the Delta variant exposes the problems with vaccine mandates that are threatening the jobs of millions of people, and raises further doubts about the case for vaccinating children. By Paul Elias Alexander, Ph.D. 7
The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It’s free.
The evidence is pouring in that COVID-19 vaccines are not as efficacious as advertised against the Delta variant that became dominant in the fall of 2021.
The Delta is learning how to thrive. The evidence has further accumulated to show that the vaccinated are showing viral loads (very high) similar to the unvaccinated, and the vaccinated are equally as infectious.
The gestalt of the findings implies that the infection explosion globally — post double vaccination e.g., Israel, UK, U.S. etc. — that we have been experiencing may be likely due to the possibility that the vaccinated are driving the epidemic/pandemic and not the unvaccinated. We have been vaccinating against the wild-type virus that is no longer a pressing concern.
The data seems to suggest that the infection is 50:50 (vaccinated versus unvaccinated) while the UK is reporting 70% of deaths in the vaccinated (Delta variant) though there is debate on differential based on < 50 versus >50 years old.
It appears that it is the vaccinated who are getting infected and thus transmitting the virus at a far greater rate. This unravels the demand for vaccine passports.ORDER TODAY: Robert F. Kennedy, Jr.’s New Book — ‘The Real Anthony Fauci’
The Marek’s disease (‘leaky’ non-sterilizing, non-neutralizing imperfect vaccines that reduce symptoms but do not stop infection or transmission) in chickens model, and the concept of the Original antigenic sin (if an initial exposure or priming of the immune system is sub-optimal (Eugyppius) e.g., vaccination with the 2020 spike protein epitopes, then the sub-optimal priming is basically “fixed.” That is to say, it prejudices the life-long immune response with re-exposure due to the immune memory or learning.
Here I present a combination of 22 studies and stories that underscore just how big a problem this is for the National Institutes of Health, Centers for Disease Control and Prevention, U.S. Food and Drug Administration and vaccine developers.
Cases in point:
1. Gazit et al. out of Israel showed that “SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected.”
2. Acharya et al. found “no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta.”
3. Riemersma et al. found “no difference in viral loads when comparing unvaccinated individuals to those who have vaccine ‘breakthrough’ infections. Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses.”
Results indicate that “if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others.”
They reported “low Ct values (<25) in 212 of 310 fully vaccinated (68%) and 246 of 389 (63%) unvaccinated individuals. Testing a subset of these low-Ct samples revealed infectious SARS-CoV-2 in 15 of 17 specimens (88%) from unvaccinated individuals and 37 of 39 (95%) from vaccinated people.”
4. Chemaitelly et al. reported a Qatar study which showed that the vaccine efficacy (Pfizer) declined to near zero by 5 to 6-months and even immediate protection after one to two months were largely exaggerated.
6. Riemersma et al. reported Wisconsin data that corroborate how the vaccinated individuals who get infected with the Delta variant can potentially (and are) transmit (ting) SARS-CoV-2 to others (potentially to the vaccinated and unvaccinated).
They found an elevated viral load in the unvaccinated and vaccinated symptomatic persons (68% and 69% respectively, 158/232 and 156/225). This implied no difference between the vaccinated and unvaccinated in terms of carriage and transmission (symptomatic).
Moreover, in the asymptomatic persons, they uncovered elevated viral loads (29% and 82% respectively) in the unvaccinated and the vaccinated respectively. This suggests that the vaccinated can be infected, harbor, cultivate and transmit the virus readily and can be doing this unknowingly.Double your impact! When you make a donation to Children’s Health Defense, your donation will be matched — up to $2 million! Donate Now!
7. Subramanian reported that observed increases in COVID-19 are unrelated to levels of vaccination when they looked at 68 countries and 2947 counties in the U.S. In other words, there is no clear discernible relationship (maybe a marginally positive association, where higher vaccination did not reduce the transmission).
8. Chau et al. (HCWs in Vietnam, Ho Chi Minh), looked at transmission of SARS-CoV-2 Delta variant among vaccinated healthcare workers in Vietnam, and their findings further ransacks the COVID-19 injection landscape and throws it into turmoil in terms of disastrous findings.
69 healthcare workers were tested positive for SARS-CoV-2. 62 participated in the clinical study. Researchers reported “23 complete-genome sequences were obtained.
They all belonged to the Delta variant, and were phylogenetically distinct from the contemporary Delta variant sequences obtained from community transmission cases, suggestive of ongoing transmission between the workers. Viral loads of breakthrough Delta variant infection cases were 251 times higher than those of cases infected with old strains detected between March-April 2020.”
9. A CDC report by Brown in the MMWR (Barnstable, Massachusetts, July 2021) found that in 469 cases of COVID-19, there were 74% that occurred in fully vaccinated persons. “The vaccinated had on average more virus in their nose than the unvaccinated who were infected.”
10. Finland nosocomial hospital outbreak (spread among HCWs and patients): “In conclusion, this outbreak demonstrated that, despite full vaccination and universal masking of HCW, breakthrough infections by the Delta variant via symptomatic and asymptomatic HCW occurred, causing nosocomical infections.”
11. Israel nosocomial hospital outbreak (also spread among HCWs and patients) both revealed that the PPE and masks were essentially ineffective in the healthcare setting. The index cases were usually fully vaccinated and most (if not all transmission) tended to occur between patients and staff who were masked and fully vaccinated, underscoring the high transmission of the Delta variant among vaccinated and masked persons.
12. UK’s Public Health England Report # 42 on page 23 raised serious concerns when it reported that “waning of the N antibody response over time and (iii) recent observations from UK Health Security Agency (UKHSA) surveillance data that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.”
13. This UK report #42 (Table 2, page 13), as well as those reports 36 to 41, show a pronounced and very troubling trend, which is that the double vaccinated persons are showing greater infection (per 100,000) than the unvaccinated, and especially in the older age groups e.g. 30 years and above.
14. CDC’s Director Rochelle Walensky admitted that the vaccines are not stopping transmission which is an admission of a failed vaccine.
15. Levin et al. “conducted a 6-month longitudinal prospective study involving vaccinated health care workers who were tested monthly for the presence of anti-spike IgG and neutralizing antibodies”… they found that “six months after receipt of the second dose of the BNT162b2 vaccine, humoral response was substantially decreased, especially among men, among persons 65 years of age or older…”
16. 40% of local Covid-19 cases in Syracuse, New York, are in the vaccinated.
18.Suthar et al. examined the durability of immune responses to the BNT162b2 mRNA vaccine. They “analyzed antibody responses to the homologous Wu strain as well as several variants of concern, including the emerging Mu (B.1.621) variant, and T cell responses in a subset of these volunteers at six months (day 210 post-primary vaccination) after the second dose …
“data demonstrate a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization with the BNT162b2 vaccine.”
19.Nordström in Sweden report on their study which shows that (cohort comprised 842,974 pairs (N=1,684,958), including individuals vaccinated with 2 doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2, and matched unvaccinated individuals) “vaccine effectiveness of BNT162b2 against infection waned progressively from 92% (95% CI, 92-93, P<0·001) at day 15-30 to 47% (95% CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23%; 95% CI, -2-41, P=0·07).”
21. Yahi et al. reported that “in the case of the Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity. Thus, ADE may be a concern for people receiving vaccines based on the original Wuhan strain spike sequence (either mRNA or viral vectors).”
22. Israel is prepping for a 4th booster shot, it reveals that the vaccine has not to live up to its inflated promise.
In conclusion, many people want the vaccine and they should be free to accept it as individuals. The public benefit of universal vaccination is now is grave doubt, and, as such, should not be expected to contribute to eliminating the social cost of the virus, much less be mandated by governments.
Originally published by Brownstone Institute.
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children’s Health Defense.
Subscribe to The Defender – It’s Free!
Dr. Alexander holds a Ph.D. He has experience in epidemiology and in the teaching clinical epidemiology, evidence-based medicine and research methodology. Alexander is a former assistant professor at McMaster University in evidence-based medicine and research methods; former COVID Pandemic evidence-synthesis consultant advisor to WHO-PAHO Washington, DC (2020) and former senior advisor to COVID Pandemic policy in Health and Human Services (HHS) Washington, DC (A Secretary), U.S. government.